Dr. William Grow, M.D.
What this data tells you about Dr. Grow
Dr. William Grow is a hematology in Winter Park, FL, with 19 years in practice. Based on federal Medicare data, Dr. Grow performed 152,534 Medicare services across 4,196 unique beneficiaries.
Between the years covered by Open Payments, Dr. Grow received a total of $2,208 from 32 pharmaceutical and/or device companies across 137 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Grow is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nivolumab injection (Opdivo) | 31,620 | $24 | $72 |
| Daratumumab injection (Darzalex) | 18,360 | $34 | $110 |
| Pembrolizumab injection (Keytruda) | 16,000 | $43 | $137 |
| Iron infusion (Feraheme) | 15,810 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 15,340 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 13,530 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 6,720 | $18 | $51 |
| Iron sucrose injection (Venofer) | 6,500 | $0 | $5 |
| Immune globulin infusion (Gammagard) | 4,452 | $36 | $108 |
| Iron infusion (Monoferric) | 4,400 | $16 | $57 |
| Dexamethasone injection (steroid) | 2,861 | $0 | $3 |
| Complete blood count (CBC) with differential | 2,772 | $8 | $29 |
| Blood draw (venipuncture) | 2,758 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,880 | $1 | $28 |
| Office visit, established patient (20-29 min) | 1,264 | $64 | $239 |
| Anti-nausea injection (ondansetron/Zofran) | 992 | $0 | $9 |
| Injection of additional new drug or substance into vein | 928 | $12 | $61 |
| Injection, leucovorin calcium, per 50 mg | 839 | $3 | $12 |
| Office visit, established patient (30-39 min) | 721 | $96 | $339 |
| Drug injection, under skin or into muscle | 672 | $10 | $69 |
| Injection, fluorouracil, 500 mg | 607 | $2 | $7 |
| Administration of chemotherapy into vein, 1 hour or less | 531 | $97 | $378 |
| Injection, carboplatin, 50 mg | 268 | $2 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 235 | $47 | $189 |
| Red blood count, automated test | 231 | $4 | $10 |
| Injection, zoledronic acid, 1 mg | 177 | $7 | $69 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 152 | $25 | $89 |
| Administration of additional new drug or substance into vein, 1 hour or less | 149 | $49 | $178 |
| Hospital follow-up visit, moderate complexity | 142 | $63 | $197 |
| Injection, diphenhydramine hcl, up to 50 mg | 139 | $1 | $3 |
| Prothrombin time test (blood clotting) | 137 | $4 | $15 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 124 | $137 | $562 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 123 | $15 | $56 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 117 | $51 | $206 |
| Hospital follow-up visit, high complexity | 107 | $93 | $285 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 94 | $1 | $6 |
| Administration of chemotherapy into vein, each additional hour | 91 | $21 | $79 |
| Administration of additional new drug or substance into vein using push technique | 80 | $42 | $170 |
| New patient office visit, complex (60-74 min) | 79 | $166 | $585 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 75 | $22 | $84 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 61 | $125 | $637 |
| Automated urinalysis | 58 | $2 | $8 |
| Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg | 57 | $305 | $1,210 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 51 | $17 | $59 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 42 | $15 | $56 |
| Drawing of blood for a medical problem | 39 | $71 | $277 |
| Infusion, normal saline solution , 1000 cc | 36 | $2 | $7 |
| New patient office visit (45-59 min) | 27 | $112 | $453 |
| Injection of drug or substance into vein | 26 | $27 | $156 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 21 | $3 | $11 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 14 | $1 | $7 |
| Initial hospital admission, high complexity | 13 | $137 | $556 |
| Transitional care management services for problem of at least moderate complexity | 12 | $158 | $533 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Grow is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Grow experienced with nivolumab injection (opdivo)?
Does Dr. Grow receive payments from pharmaceutical companies?
How do Dr. Grow's costs compare to other hematologys in Winter Park?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology